Impacto do Enriquecimento do Risco Cardiovascular na Incidência de Eventos Adversos Cardiovasculares Graves no Programa Clínico de Tofacitinibe em Artrite Reumatoide
Ann Rheum Dis. 2023;82(4):575–577 doi: 10.1136/ard-2022-223406
Data suggest that an important difference between P123LTE and ORAL Surveillance was the proportion of patients with a history of atherosclerotic CV disease (ASCVD).